Post-covid sindrom – aktuelni izazov u radu izabranog lekara

Irena Pušica; Ana Lončar

doi:10.5937/opmed0-52731

Irena Pušica Dom zdravlja "Novi Beograd" https://orcid.org/0000-0003-1423-0416
Ana Lončar Dom zdravlja "Novi Beograd"

DOI: https://doi.org/10.5937/opmed0-52731

Ključne reči: SARS-CoV-2, COVID-19, post-akutni COVID-19 sindrom

Sažetak

Uvod. Post-COVID sindrom se odlikuje značajnom
kliničkom varijabilnošću i obuhvata sekvele oboljenja COVID-
19 koje su prisutne duže od tri meseca nakon infekcije
SARS-CoV-2.
Cilj istraživanja bio je utvrđivanje prisustva i trajanja
post-COVID sindroma, učestalosti pojedinačnih simptoma i
faktora koji mogu uticati na njihovo ispoljavanje.
Metod. Sproveli smo studiju preseka kod pacijenata
koji su bili zaraženi SARS-CoV-2. Ispitanici su anketirani
pomoću upitnika u drugoj polovini 2023. godine. Podaci su
analizirani deskriptivnom statistikom, Kruskal-Wallis testom
i Bonferonijevim testom višestrukih poređenja parova korišćenjem
SPSS 26. Statistički značajnom se smatrala p vrednost
<0,05.
Rezultati. Od ukupno 90 ispitanika, 15,6% nije imalo
post-COVID simptome. Kod 24,4% ispitanika tegobe su
trajale duže od šest meseci. Najviše je bilo zastupljeno brzo
zamaranje (60%), hronični umor (53,3%) i smanjena koncentracija
(45,6%). U definisanim starosnim grupama, postojala
je značajna razlika za prisustvo tahikardije, znojenja i opstipacije
(p<0,05). U odnosu na body mass index, uočena je značajna
razlika za prisustvo kašlja, bola u grudima, opstipacije
i poremećaja seksualne funkcije (p<0,05). U zavisnosti od
pušačkog statusa, zabeležena je značajnа razlika za pojavu
noćnih mora, glavobolje, anksioznosti, bola u stomaku i dijareje
(p<0,05). U odnosu na prisustvo komorbiditeta, postojala
je značajna razlika za opadanje kose (p<0,05).
Zaključak. Za lečenje ovog stanja neophodan je holistički
pristup pacijentu, pa je uloga izabranog lekara od velikog
značaja.

Reference

Pintos-Pascual I, Moreno-Torres V, Ibánez-Estéllez F, Corrales-Rodriguez P, Treviño A, Corpas M, et al. Is SARS-CoV-2 the only cause of long-COVID? AIDS Rev 2022;24(4): 183–96.

Worldometer. COVID-19: Coronavirus pandemic. 2024. https://www.worldometers.info/coronavirus/ Pristupljeno 15. februara 2024.

Pierce JD, Shen Q, Cintron SA, Hiebert JB. Post-COVID-19 Syndrome. Nurs Res 2022; 71(2):164–74.

Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, Reid TR. A Review of Persistent Post-COVID Syndrome (PPCS). Clin Rev Allergy Immunol 2023; 64(1):66–74.

Jimeno-Almazán A, Pallarés JG, Buendía-Romero Á, Martínez-Cava A, Franco-López F, Sánchez-Alcaraz Martínez BJ, et al. Post-COVID-19 Syndrome and the Potential Benefits of Exercise. Int J Environ Res Public Health 2021;18(10):5329.

Kaur A, Michalopoulos C, Carpe S, Congrete S, Shahzad H, Reardon J, et al. Post-COVID-19 Condition and Health Status. COVID 2022;2(1):76–86.

Pfaff ER, Madlock-Brown C, Baratta JM, Bhatia A, Davis H, Girvin A, et al. Coding Long COVID: Characterizing a new disease through an ICD-10 lens. BMC Med 2023; 21(1):58.

Ortona E, Malorni W. Long COVID: to investigate immunological mechanisms and sex/gender related aspects as fundamental steps for tailored therapy. Eur Respir J 2022; 59(2):2102245.

Parotto M, Gyöngyösi M, Howe K, Myatra SN, Ranzani O, Shankar-Hari M, et al. Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations. Lancet Respir Med 2023;11(8):739–54.

Peghin M, De Martino M, Palese A, Gerussi V, Bontempo G, Graziano E, et al. Post-COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients. Clin Microbiol Infect 2022;28(8):1140–8.

Ståhlberg M, Reistam U, Fedorowski A, Villacorta H, Horiuchi Y, Bax J, et al. Post-COVID-19 Tachycardia Syndrome: A Distinct Phenotype of Post-Acute COVID-19 Syndrome. Am J Med 2021;134(12):1451–6.

Raveendran AV, Misra A. Post COVID-19 Syndrome ("Long COVID") and Diabetes: Challenges in Diagnosis and Management. Diabetes Metab Syndr 2021;15(5):102235.

Zayet S, Zahra H, Royer PY, Tipirdamaz C, Mercier J, Gendrin V, et al. Post-COVID-19 Syndrome: Nine Months after SARS-CoV-2 Infection in a Cohort of 354 Patients: Data from the First Wave of COVID-19 in Nord Franche-Comté Hospital, France. Microorganisms 2021;9(8):1719.

Visco V, Vitale C, Rispoli A, Izzo C, Virtuoso N, Ferruzzi GJ, et al. Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems. J Clin Med 2022;11(3):524.

Lippi G, Sanchis-Gomar F, Henry BM. COVID-19 and its long-term sequelae: what do we know in 2023? Pol Arch Intern Med 2023;133(4):16402.

Fernandez-de-Las-Peñas C, Notarte KI, Macasaet R, Velasco JV, Catahay JA, Ver AT, et al. Persistence of post-COVID symptoms in the general population two years after SARS-CoV-2 infection: A systematic review and meta-analysis. J Infect 2024;88(2):77–88.

Jiang J, Li Y, Jiang Q, Jiang Y, Qin H, Li Y. Early use of oral antiviral drugs and the risk of post COVID-19 syndrome: A systematic review and network meta-analysis. J Infect 2024;89(2):106190.

Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, et al. Risk Factors Associated With Post-COVID-19 Condition: A Systematic Review and Meta-analysis. JAMA Intern Med 2023;183(6):566–80.

Relan P, Murthy S, Marshall JC, Annane D, Chevret S, Arabi YM, et al. World Health Organization Respiratory Support Research Group; World Health Organization O2CoV2 International Study Steering Committee. WHO O2CoV2: oxygen requirements and respiratory support in patients with COVID-19 in low-and-middle income countries-protocol for a multicountry, prospective, observational cohort study. BMJ Open 2023; 13(8):e071346.

Šipetić Grujičić S, Miljuš D, Soldatović I, Nikolić A, Vujčić I. Prevalencija i faktori rizika od prehipertenzije i hipertenzije kod odrasle populacije u Republici Srbiji - studija preseka. Vojnosanit Pregl 2020;77(6):590–600.

Fung KW, Baye F, Baik SH, Zheng Z, McDonald CJ. Prevalence and characteristics of long COVID in elderly patients: An observational cohort study of over 2 million adults in the US. PLoS Med 2023;20(4):e1004194.

Monzon ELA, Li KL. Incidence of post-COVID-19 syndrome and its association with COVID-19 severity in a tertiary private hospital: Prospective cohort study. IJID Reg 2023;9:14–7.

Almas T, Malik J, Alsubai AK, Jawad Zaidi SM, Iqbal R, Khan K, et al. Post-acute COVID-19 syndrome and its prolonged effects: An updated systematic review. Ann Med Surg (Lond) 2022;80:103995.

Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021;38:101019.

Sathyamurthy P, Madhavan S, Pandurangan V. Prevalence, Pattern and Functional Outcome of Post COVID-19 Syndrome in Older Adults. Cureus 2021;13(8):e17189.

Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun 2022;101:93–135.

Garout MA, Saleh SAK, Adly HM, Abdulkhaliq AA, Khafagy AA, Abdeltawab MR, et al. Post-COVID-19 syndrome: assessment of short- and long-term post-recovery symptoms in recovered cases in Saudi Arabia. Infection 2022;50(6):1431–9.

Sharma P, Bharti S, Garg I. Post COVID fatigue: Can we really ignore it? Indian J Tuberc 2022;69(2):238–41.

Parashar K, Adlam T, Potts G. The Impact of Hyperhidrosis on Quality of Life: A Review of the Literature. Am J Clin Dermatol 2023;24(2):187–98.

Awad NEHA, Obaid ZM, Zaky MS, Elsaie ML. Hair disorders associated with post-COVID-19 infection in females: a cross-sectional study. Ir J Med Sci 2024;193(2):761–7.

Brar E, Saxena A, Dukler C, Xu F, Saxena D, Cheema Brar P, et al. Vaping, SARS-CoV-2, and Multisystem Inflammatory Syndrome: A Perfect Storm. Front Pediatr 2021;9: 647925.

de Granda-Orive JI, Solano-Reina S, Jiménez-Ruiz CA. Are Smoking and Vaping Risk Factors of Developing Long and Persistent Post-COVID-19? Open Respir Arch 2022; 4(4):100195.

Debski M, Tsampasian V, Haney S, Blakely K, Weston S, Ntatsaki E, et al. Post-COVID-19 syndrome risk factors and further use of health services in East England. PLOS Glob Public Health 2022;2(11):e0001188.